Literature DB >> 4042543

Changes in plasma free 3,4-dihydroxyphenylethylene glycol and noradrenaline levels after acute alcohol administration.

L G Howes, J L Reid.   

Abstract

The effects of alcohol (0.9 g/kg) compared with placebo (400 ml of orange juice) on plasma noradrenaline and 3,4-dihydroxyphenylethylene glycol levels, and on erect and supine blood pressures and heart rates, were studied in eight normal male volunteers. Alcohol caused a rise in noradrenaline levels that commenced approximately 30 min after drinking and lasted about 4 h. In contrast, 3,4-dihydroxyphenylethylene glycol levels fell immediately after alcohol administration and remained low for at least 6 h. Acute alcohol administration alters noradrenaline catabolism, and may have a dual effect of increasing noradrenaline release and decreasing noradrenaline clearance. Alcohol caused a transient rise in erect and supine blood pressures that preceded the rise in plasma noradrenaline. Thereafter erect blood pressures fell compared with control. This fall was associated with a progressive rise in both supine and erect rates, and reached a maximum several hours after the maximum levels of blood alcohol. The major effect of acute alcohol administration is to lower blood pressure and induce a reflex tachycardia. Changes in noradrenaline and 3,4-dihydroxyphenylethylene glycol levels did not readily explain changes in blood pressure or heart rate, suggesting that alcohol induced changes in noradrenaline metabolism occur largely independent of changes in blood pressure and heart rate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042543     DOI: 10.1042/cs0690423

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  11 in total

Review 1.  Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders.

Authors:  Sara K Blaine; Rajita Sinha
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

Review 2.  CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety.

Authors:  Kristen E Pleil; Mary Jane Skelly
Journal:  Alcohol       Date:  2018-02-02       Impact factor: 2.405

3.  Central Noradrenergic Interactions with Alcohol and Regulation of Alcohol-Related Behaviors.

Authors:  Elena M Vazey; Carolina R den Hartog; David E Moorman
Journal:  Handb Exp Pharmacol       Date:  2018

4.  The neurobiological markers of acute alcohol's subjective effects in humans.

Authors:  Raphael Hamel; Olivier Demers; Camille Boileau; Marie-Laurence Roy; Hugo Théoret; Pierre-Michel Bernier; Jean-Francois Lepage
Journal:  Neuropsychopharmacology       Date:  2022-06-14       Impact factor: 8.294

5.  Role of alcohol in clinical nephrology.

Authors:  A Heidland; W H Hörl; R M Schaefer; M Teschner; J Weipert; E Heidbreder
Journal:  Klin Wochenschr       Date:  1985-09-16

6.  Ethanol and platelet intracellular free calcium concentrations.

Authors:  K R Lees; S M Barr; L Butters; P C Rubin
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

7.  Alcohol ingestion lowers supine blood pressure, causes splanchnic vasodilatation and worsens postural hypotension in primary autonomic failure.

Authors:  K R Chaudhuri; S Maule; T Thomaides; D Pavitt; C J Mathias
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

Review 8.  Alcohol Effects on Stress Pathways: Impact on Craving and Relapse Risk.

Authors:  Sara K Blaine; Verica Milivojevic; Helen Fox; Rajita Sinha
Journal:  Can J Psychiatry       Date:  2016-02-09       Impact factor: 4.356

Review 9.  Hypertension and chronic ethanol consumption: What do we know after a century of study?

Authors:  Katia Colombo Marchi; Jaqueline Jóice Muniz; Carlos Renato Tirapelli
Journal:  World J Cardiol       Date:  2014-05-26

Review 10.  Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine.

Authors:  Paul J Fitzgerald
Journal:  Subst Abuse       Date:  2013-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.